Par Formulations Private Limited, the operating subsidiary of Par Pharmaceuticals Companies Inc. (:PRX) received its first approval from the US Food and Drug Administration (:FDA). The FDA approved ...

Par Formulations Private Limited, (formerly Edict Pharmaceuticals Private Limited), an operating subsidiary of Par Pharmaceutical Companies, Inc. has received the US Food and Drug Administration (FDA) ...

Par Formulations (formerly Edict Pharmaceuticals) announced its first FDA approval for Labetalol HCl Tablets, the generic version of Prometheus Labs’ Trandate tablets. Labetalol HCl is a ...

Par Formulations Private Limited, the operating subsidiary of Par Pharmaceuticals Companies Inc. ( PRX) received its first approval from the US Food and Drug Administration (FDA). The FDA approved the ...